TrialDrug design, development and therapy2014

Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.

David Pierce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.